4HGLIST J, RODRIGUEZ J L. Clincal guide line for diagnosis and management of melioicbsis[J]. Rev hst Med Top Sao Paub,2006,48:1-4.
5CHAN Y Y,TAN TMC,ONG Y M,et al. A multi- drug efflux pump in Burkholderia pseudomalleiEJ]. Antimicrob Agent Chemother, 2004,48 : 1128 -- 1135.
6HOIDEN M T,TITBALL R W,PEACOCK S J,et al. Epidemiological surveillance of melioidosis in Singa- pore[J]. Proc Natl Acad Sci USA, 2004,101 :14240-- 14245.
7CHIERAUL W, ANUNNATSIRI S, CHAOWAGUL W,et al. Addition of Trimethprin-sulfamethoxazole to ceftazidime during parenteral treatment of Melioidosis is not associated with a longterm outcome benefit[J]. Clin Infecr Dis, 2007,45 : 521 -- 23.
4[1]Su H P,Yang H W,Chen Y L,et al.Prevalence of melioidosis in the Er-Ren River Basin,Taiwan:implications for transmission[J].Clin Microbiol.,2007,45(8):2599-603.
5[3]White N J.Melioidosis[J].Lancet,2003,361(9370):1715-1722.
6[6]Inglis T J,Olim D B,Sousa A d,et al.Melioidosis in the Americas[J].Am J Trop Med Hyg,2006,75(5):947-954.
7[7]Warner J M,Pelowa D B,Currie B J,et al.Melioidosis in a rural community of Western Province,Papua New Guinea[J].Trans R Soc Trop Med Hyg,2007,101(8):809-813.
8[8]Shibuya H,Taniguchi Y,Tashiro N,et al.A Japanese case of melioidosis presenting as multiple organ lesions accompanied by sepsis and disseminated intravascular coagulation,after a visit to Thailand[J].Kansenshogaku Zasshi.2007,81(3):297-301.
9[9]Virginio C G,Teixeira M F,Frota C C,et al.Phenotypic characterization of three clinical isolates of Burkholderia pseudomallei in Ceará,Brazil[J].Mem Inst Oswaldo Cruz,2006,101(1):95-97.
10[10]Jain V K,Jain D,Kataria H,et al.Melioidosis:A review of orthopedic manifestations,clinical features,diagnosis and management[J].Indian J Med Sci,2007,61(10):580-590.
